BioNTech Interest Expense from 2010 to 2025

BNTX Stock  USD 97.05  3.59  3.57%   
BioNTech Interest Expense yearly trend continues to be fairly stable with very little volatility. Interest Expense is likely to outpace its year average in 2025. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
2018-06-30
Previous Quarter
M
Current Value
2.2 M
Quarterly Volatility
34.9 M
 
Covid
Check BioNTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioNTech's main balance sheet or income statement drivers, such as Net Interest Income of 446.2 M, Interest Income of 459.5 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 9.02, Dividend Yield of 0.011 or PTB Ratio of 1.41. BioNTech financial statements analysis is a perfect complement when working with BioNTech Valuation or Volatility modules.
  
Check out the analysis of BioNTech Correlation against competitors.

Latest BioNTech's Interest Expense Growth Pattern

Below is the plot of the Interest Expense of BioNTech SE over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. BioNTech's Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioNTech's overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Slightly volatile
   Interest Expense   
       Timeline  

BioNTech Interest Expense Regression Statistics

Arithmetic Mean7,869,647
Geometric Mean2,039,915
Coefficient Of Variation207.43
Mean Deviation9,952,354
Median676,000
Standard Deviation16,323,952
Sample Variance266.5T
Range64.4M
R-Value0.38
Mean Square Error244.3T
R-Squared0.14
Significance0.15
Slope1,303,017
Total Sum of Squares3997.1T

BioNTech Interest Expense History

202514.6 M
202412.6 M
2023569.9 K
202218.9 M
20215.4 M
202064.9 M
20191.7 M

About BioNTech Financial Statements

BioNTech investors use historical fundamental indicators, such as BioNTech's Interest Expense, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioNTech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Expense12.6 M14.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.